Contact this trialFirst, we need to learn more about you.
Immunomodulator
F-652 +1 More for Coronavirus
Recruiting0 awardsPhase 2
New Orleans, Louisiana
This trial tests a new medicine called F-652 in adults with serious COVID-19 symptoms. It aims to see if F-652 can help these patients recover faster and reduce the severity of their illness. The medicine is given through an IV infusion.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service